Mesa Laboratories Corp. (MLAB) - Ratio of Long-Term Indebtedness to Capital
Mesa Laboratories, Inc. (MLAB) develops medical quality verification tools, as confirmed by current price action where the indicator stands at 0.84. A model based on the regular sale of components ensures a steady cash flow. Business growth relies on the implementation of measurement systems in clinics to execute high-margin tests. The company is currently focusing on M&A transactions, offering sterilization solutions for the pharmaceutical sector and biosafety.
Analytical breakdowns for Mesa Laboratories, Inc.
To protect a portfolio, it is critical to assess the share of long-term liabilities in equity, which allows for the determination of the business's dependence on borrowed funds and the impact of WACC on asset value. This long-term debt-to-capital coverage ratio confirms the ability of Mesa Laboratories, Inc. (MLAB) to finance high-tech production robotization and the compensation of leading scientists without risking financial stability.